メインコンテンツにスキップ

Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin

Authors: Nikunjkumar Patel, James F. Clarke, Farzaneh Salem, Tariq Abdulla, Frederico Martins, Sumit Arora, Eleftheria Tsakalozou, Arran Hodgkinson, Omid Arjmandi-Tash, Sinziana Cristea, Priyanka Ghosh, Khondoker Alam, Sam G. Raney, Masoud Jamei, Sebastian Polak Physiologically-based pharmacokinetic models combine knowledge about physiology, drug product properties, such as physicochemical parameters, absorption, distribution, metabolism, excretion characteristics, formulation attributes, and … Continued

Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb

Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies, and impact of generative AI on biosimulation and regulatory sciences    RADNOR, PA– April. 18, 2024 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced that it will host the first-ever Certainty Conference. At this event, … Continued

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform

PRINCETON, NJ – 2024年4月16日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued

Certara Announces New Corporate Headquarters

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – 2024年4月15日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued

Hallmarks of neurodegenerative disease: A systems pharmacology perspective

Authors: Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau-Veilleux, Matthew Moye, Kazutaka Sekiguchi, Guy Meno-Tetang, Aparna Mohan, R. Maithreye, Veena A. Thomas, Frank Gibbons, Antonio Cabal, Jean-Marie Bouteiller, Hugo Geerts Age-related central neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, are a rising public health concern and have been plagued by repeated drug … Continued

1 of 47
Powered by Translations.com GlobalLink OneLink Software